The global Active Pharmaceutical Ingredients Market was valued at USD xx million in 2017 and is forecasted to reach USD xx million by 2025, with a CAGR of xx% during the forecast period (2018-2025).
Patent expiries of the branded drugs, increased uptake of biologics, government initiatives for biomedical research are majorly driving the global Active Pharmaceutical Ingredients Market. However, Unfavourable Drug Price Control Policies Across Various Countries is holding back the growth of the market.
Patent rights are the most important concept in the pharmaceutical markets. Due to the protection by patents, most of the technologies are not accessible by most of the companies in the market. Patent expirations of the drugs lead to the generic versions of the molecules, and the manufacturers bear the cost. This will help in the decrease of the overall cost of the ingredient thereby increasing the number of users, which further increases the overall market for the ingredients. For instance, the patent for Tevas long-acting MS med Copaxone 40 mg, which has a revenue of $3.48 billion in the U.S. is expired allowing of the manufacturers to use the technology and produce the drug 80% to 85%.
The global market is segmented based on Type, Nature, Application, and Manufacturing type. By type, the market is divided into Synthetic API and Biotech API. The Biotech APIs include Monoclonal Antibodies, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Recombinant Enzymes, Antibiotics, Statins, and Others.
By Manufacturing type, the market is divided into Captive and Merchant. Captive API is the largest segment covering a major part of the global API market with a market share of approximately 61% while the remaining is taken by merchant API.
For More Details Sample/Inquire at:
By End User, the market is classified by Patients with chronical diseases, Physicians, Hospitals, Parents/Relatives, and Others. Need for continuous monitoring of the patients, ease of access to premium healthcare services at a relatively low cost is encouraging the end users to prefer for Active Pharmaceutical Ingredients.
The report segments the geographies by regions, which include North America, South America, Europe, Asia Pacific and RoW.
North America dominates the global API market with a share of approximately 40.1%, followed by Europe with 24%. Increasing medical requirements, advancement in R&D and innovations in this regions are favoring the growth of the market.
The report covers the factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles. The global Active Pharmaceutical Ingredients market is segmented based on Nature, the market is classified as Generic API and Innovator API. Further, the market is classified based on Application as Cardiovascular, Diabetes, Oncology, Orthopaedics, Neurology, NSAIDS, and Others.
The report profiles the following companies, which include Aurobindo Pharma, Mylan, Teva Active Pharmaceutical Ingredients, Ipca, Aceto Corporation, Arevipharma GmbH, Dr. Reddys Laboratories, Pfizer, Inc, Novartis International AG, Sanofi, Ranbaxy, and Sun Pharma.
Browse Full Report at:
Why purchase the report?
- Visualize the composition of the Active Pharmaceutical Ingredients market across each indication, in terms of type and applications, highlighting the key commercial assets and players.
- Identify commercial opportunities in Active Pharmaceutical Ingredients by analyzing trends and co-development deals.
- This is the most comprehensive study on Active Pharmaceutical Ingredients to date.
- Excel data sheet with thousands of data points of the Active Pharmaceutical Ingredients market level 4/5 segmentation
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
- Product mapping in excel for the key Active Pharmaceutical Ingredients products of all major market players
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a five to seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future Outlook.
MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. MarketInsightsReports provides United States and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
+1 (704) 266-3234 | [email protected]
Connect With us on: